Back

Albumin is a prognostic marker of long-term outcomes in patients with triple-vessel coronary artery Disease: a large data from China

3 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 6 - Epidemiology and prevention Nutrition, Malnutrition and Heart Disease ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Xueyan Zhao

Fuwai Hospital, CAMS and PUMC, Beijing (China)

12 More presentations in this session

Presentation thumbnail
Professor A. Fijalkowska (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Professor J. Redfern (Gold Coast, AU)
Abstract Slides
Presentation thumbnail
Professor S. Stranges (London, CA)
Abstract Slides
Presentation thumbnail
Miss C. Xia (Groningen, NL)
Abstract
Presentation thumbnail
Professor J. Kerr Saraiva (Sao Paulo, BR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Epidemiology and prevention

The Event

Event poster

ESC Congress 2019

3 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic impact of follow-up serum albumin after acute myocardial infarction
30 June 2021
thumbnail
Congress Presentation
Association between genetic polymorphisms in multiple thrombosis-related genes and long-term prognosis in coronary artery disease patients: a large-scale cohort study
1 September 2025
thumbnail
Congress Presentation
Risk assessment and clinical outcome for CABG in patients with coronary artery disease and severely impaired left ventricular ejection fraction
22 May 2023
thumbnail
Congress Presentation
Urinary albumin-to-creatinine ratio and all-cause and cause-specific mortality in chronic kidney disease patients with suspected or known coronary artery disease: the EXCEED-J Study
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources